Brass L F, Woolkalis M J
Department of Medicine, University of Pennsylvania, Philadelphia 19104.
Biochem J. 1992 Jan 1;281 ( Pt 1)(Pt 1):73-80. doi: 10.1042/bj2810073.
Thrombin is thought to stimulate responsive cells by cleaving cell-surface receptors coupled to intracellular second-messenger-generating enzymes via G-proteins. In order to understand this process better, we have examined the regulation of adenylate cyclase by thrombin in the megakaryoblastic HEL cell line and compared it with platelets. A notable difference was found. In HEL-cell membrane preparations, thrombin inhibited cyclic AMP (cAMP) formation by a pertussis-toxin-sensitive mechanism comparable with that observed in platelets. In contrast, when added to intact HEL cells, thrombin activated adenylate cyclase and caused an increase in cAMP formation synergistic with that produced by forskolin and prostaglandin I2. This increase, which was not seen with platelets, was accompanied by an increase in cAMP metabolism by phosphodiesterase. Like other responses to thrombin, the increase in cAMP formation required proteolytically active thrombin and was subject to homologous desensitization. An equivalent response could be evoked by the addition of a polypeptide, derived from the N-terminus of the thrombin receptor, that has been shown to activate the receptor. The effects of thrombin could not, however, be reproduced by the addition of phorbol ester and the Ca2+ ionophore, A23187, nor be prevented with inhibitors of arachidonate metabolism. Preincubation of the cells with adrenaline, which inhibited Gs-mediated activation of adenylate cyclase, or pertussis toxin, which inhibited phospholipase C activation, had no effect on thrombin-induced cAMP formation. These results suggest that thrombin can regulate cAMP formation by two different mechanisms. First, thrombin can inhibit adenylate cyclase in a Gi-dependent manner. This effect predominates in HEL-cell membrane preparations, as it does in platelets, but is not detectable when thrombin is added to intact HEL cells. Instead, in intact HEL cells thrombin activates adenylate cyclase. Although clearly receptor-mediated, this response does not appear to involve Gi, Gs, protein kinase C, eicosanoid formation or changes in the cytosolic Ca2+ concentration.
凝血酶被认为通过裂解与经由G蛋白与细胞内第二信使生成酶偶联的细胞表面受体来刺激反应性细胞。为了更好地理解这一过程,我们研究了巨核母细胞性HEL细胞系中凝血酶对腺苷酸环化酶的调节作用,并将其与血小板进行了比较。结果发现了一个显著差异。在HEL细胞膜制剂中,凝血酶通过一种对百日咳毒素敏感的机制抑制环磷酸腺苷(cAMP)的形成,这与在血小板中观察到的情况类似。相比之下,当将凝血酶添加到完整的HEL细胞中时,它会激活腺苷酸环化酶,并导致cAMP形成增加,这种增加与福斯高林和前列腺素I2产生的增加具有协同作用。血小板中未观察到这种增加,同时它还伴随着磷酸二酯酶对cAMP代谢的增加。与对凝血酶的其他反应一样,cAMP形成的增加需要具有蛋白水解活性的凝血酶,并且会发生同源脱敏。添加源自凝血酶受体N端的一种已被证明能激活该受体的多肽可引发同等反应。然而,添加佛波酯和Ca2+离子载体A23187无法重现凝血酶的作用,花生四烯酸代谢抑制剂也无法阻止其作用。用抑制Gs介导的腺苷酸环化酶激活的肾上腺素或抑制磷脂酶C激活的百日咳毒素对细胞进行预孵育,对凝血酶诱导的cAMP形成没有影响。这些结果表明,凝血酶可以通过两种不同机制调节cAMP的形成。首先,凝血酶可以以Gi依赖的方式抑制腺苷酸环化酶。这种作用在HEL细胞膜制剂中占主导,在血小板中也是如此,但当将凝血酶添加到完整的HEL细胞中时则无法检测到。相反,在完整的HEL细胞中,凝血酶会激活腺苷酸环化酶。尽管这一反应显然是由受体介导的,但似乎不涉及Gi、Gs、蛋白激酶C、类花生酸的形成或胞质Ca2+浓度的变化。